Biosymetrics
1 known investors
Find your way into Biosymetrics
Sign up to see every warm intro you have to Biosymetrics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biosymetrics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioSymetrics builds an AI/ML and in vivo validation platform that combines clinical records, genomic profiles, and experimental data to identify disease subtypes, biomarkers, and higher-confidence drug targets for precision medicines. It applies this workflow to areas including precision neurology, neuropsychiatry, rare neurological disorders, and biodefence, serving drug discovery and clinical trial optimization.
Investors · 1
Frequently asked questions
- What does Biosymetrics do?
- BioSymetrics builds an AI/ML and in vivo validation platform that combines clinical records, genomic profiles, and experimental data to identify disease subtypes, biomarkers, and higher-confidence drug targets for precision medicines. It applies this workflow to areas including precision neurology, neuropsychiatry, rare neurological disorders, and biodefence, serving drug discovery and clinical trial optimization.
- Who are Biosymetrics's investors?
- Biosymetrics's investors include Dasein Capital.